Cognition Therapeutics Inc (CGTX)
1.94
+0.03
(+1.57%)
USD |
NASDAQ |
May 10, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Enterprise Value: 43.41M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 43.41M |
| May 09, 2024 | 42.21M |
| May 08, 2024 | 45.81M |
| May 07, 2024 | 42.61M |
| May 06, 2024 | 45.41M |
| May 03, 2024 | 43.01M |
| May 02, 2024 | 45.01M |
| May 01, 2024 | 43.77M |
| April 30, 2024 | 42.17M |
| April 29, 2024 | 42.97M |
| April 26, 2024 | 43.77M |
| April 25, 2024 | 42.97M |
| April 24, 2024 | 45.37M |
| April 23, 2024 | 45.77M |
| April 22, 2024 | 40.17M |
| April 19, 2024 | 39.37M |
| April 18, 2024 | 39.37M |
| April 17, 2024 | 41.77M |
| April 16, 2024 | 41.37M |
| April 15, 2024 | 42.17M |
| April 12, 2024 | 44.07M |
| April 11, 2024 | 49.27M |
| April 10, 2024 | 44.87M |
| April 09, 2024 | 46.87M |
| April 08, 2024 | 48.47M |
| Date | Value |
|---|---|
| April 05, 2024 | 47.67M |
| April 04, 2024 | 42.87M |
| April 03, 2024 | 44.47M |
| April 02, 2024 | 38.07M |
| April 01, 2024 | 41.67M |
| March 28, 2024 | 41.60M |
| March 27, 2024 | 41.60M |
| March 26, 2024 | 41.99M |
| March 25, 2024 | 41.60M |
| March 22, 2024 | 41.21M |
| March 21, 2024 | 44.33M |
| March 20, 2024 | 47.45M |
| March 19, 2024 | 41.99M |
| March 18, 2024 | 43.16M |
| March 15, 2024 | 41.60M |
| March 14, 2024 | 40.04M |
| March 13, 2024 | 28.99M |
| March 12, 2024 | 30.29M |
| March 11, 2024 | 34.51M |
| March 08, 2024 | 34.51M |
| March 07, 2024 | 34.51M |
| March 06, 2024 | 36.78M |
| March 05, 2024 | 38.72M |
| March 04, 2024 | 33.53M |
| March 01, 2024 | 35.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.56M
Minimum
Nov 10 2022
269.09M
Maximum
Nov 09 2021
34.06M
Average
14.82M
Median
Apr 14 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.377M |
| Palatin Technologies Inc | 27.47M |
| iBio Inc | 16.31M |
| Theriva Biologics Inc | -9.017M |
| Oragenics Inc | 6.666M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.151M |
| Total Expenses (Quarterly) | 9.19M |
| EPS Diluted (Quarterly) | -0.27 |
| Earnings Yield | -47.42% |